Transforming growth factor prostate cancer

H17. Hofer, D. R., Sherwood, E. R., Bromberg, W. D., Mendelsohn, J., Lee, C., and Kozlowski, J. M., Autonomous growth of androgen-independent human prostatic carcinoma cells Role of transforming growth factor alpha. Cancer Res. 51, 2780-2785 (1991). [Pg.148]

Danielpour D (2005) Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 41 846-857... [Pg.1233]

Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG. 2003. Transforming growth factor-betal activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22 4314-4332. [Pg.393]

G24. Guo, Y., and Kyprianou, N., Overexpression of transforming growth factor (TGF) beta type II receptors restores TGF-beta 1 sensitivity and signalling in human prostate cancer cells. Cell Growth Different. 9, 185-193 (1998). [Pg.147]

G25. Guo, Y., Jacobs, S. C., and Kyprianou, N., Down-regulation of protein and mRNA expression for transforming growth factor-beta 1C i 1 (11) type I and type II receptors in human prostate cancer. Int. J. Cancer. 71, 573-579 (1997). [Pg.147]

K3. Kim, I. Y., Ahn, H. J., Lang, S., Oefelein, M. G., Oyasu, R., et al., Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer... [Pg.149]

L2. Lamm, M. L., Sintich, S. M., and Lee, C., A proliferative effect of transforming growth factor-betal on a human prostate cancer cell line, TSU-Prl. Endocrinology 139, 787-790 (1998). [Pg.150]

L14. Lui X. H., Wiley, H. S., and Meikle, A. W., Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-a (TGF-a) and epidermal growth factor (EGF)/TGF-a receptor. J. Clin. Endocrinol. Metab. 77, 1472—1478 (1993). [Pg.151]

Scher, H. I., Sarkis, A., Reuter, V., Cohen, D., Netto, G., et al., Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin. Cancer Res. 1, 545-550 (1995). [Pg.156]

Seghal, I., Bailey, P. A., and Thompson, T. C., Transforming growth factor beta 1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res. 56, 3359-3365 (1996). [Pg.156]

Steiner, M. S., Transforming growth factor-13 and prostate cancer World J. Urol. 13, 329-336 (1995). [Pg.156]

W7. Wikstrom, P., Stattin, P., Franck-Lissbrandt, I., Damber, J. E., and Bergh, A., Transforming growth factor beta 1 is associated with angiogenesis, metastasis, and poor outcome in prostate cancer. Prostate 37, 19-29 (1998). [Pg.159]

W10. Williams, R. H., Stapleton, A. M., Yang, G., Truong, L. D., Rogers, E., el al., Reduced levels of transforming growth factor beta receptor type II in human prostate cancer An immunohistochemical study. Clin. Cancer Res. 2,635—640 (1996). [Pg.159]

Wikstrom P, Bergh A, Dumber JE. Transforming growth factor-betal and prostate cancer. Scand J Urol Nephrol. 2000 34 85. [Pg.653]

Wikstrom P, Dumber J, Bergh A. Role of transforming growth factor-betal in prostate cancer. Microsc Res Tech.2001 52 411. [Pg.653]

Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim C-S, Fine RL, Robertson CN (1997) Fenretinide induction of apoptosis and endogenous transforming growth factor p in PC-3 prostate cancer cells. Cell Growth Differs 101-111... [Pg.248]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...